<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03553420</url>
  </required_header>
  <id_info>
    <org_study_id>ECLip Registry</org_study_id>
    <nct_id>NCT03553420</nct_id>
  </id_info>
  <brief_title>Registry for Patients With Lipodystrophy</brief_title>
  <acronym>ECLip Registry</acronym>
  <official_title>Osse Registry for Patients With Lipodystrophy Run by the European Consortium of Lipodystrophies (ECLip)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sorbonne University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Cambridge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Endocrinology Research Centre, Moscow</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Amsterdam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro Hospitalar De São João, E.P.E.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Martin-Luther-Universität Halle-Wittenberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jagiellonian University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dokuz Eylul University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS Azienda Ospedaliero-Universitaria di Bologna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Rome Tor Vergata</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pisa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Santiago de Compostela</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cyprus Institute of Neurology and Genetics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Università degli Studi del Piemonte Orientale &quot;Amedeo Avogadro&quot;</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Marseille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Westfälische Wilhelms-Universität Münster</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Szeged University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto de Ciências Biomédicas Abel Salazar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Medical Centre Ljubljana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Ulm</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Given the lack of knowledge on lipodystrophies, the medical and social responsibility for the&#xD;
      persons affected by it calls for the monitoring of the progression over long periods of time.&#xD;
      Sensible clinical and basic research into rare diseases such as lipodystrophy is only&#xD;
      possible in multi-location networks with sufficient case numbers. Also, reliable information&#xD;
      on the incidence of certain manifestation patterns, health status, etc. is of utmost&#xD;
      importance for health care and health policy in this rare disease.&#xD;
&#xD;
      Therefore, the European Consortium of Lipodystrophies (ECLip), an association of European&#xD;
      experts on lipodystrophy, has launched a registry (OSSE) for lipodystrophies which is&#xD;
      committed to help to improve the research conditions by consolidating this kind of&#xD;
      information in a registry.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As lipodystrophies are rare diseases subdivided into yet rarer sub-groups, research in this&#xD;
      field requires international co-operation.&#xD;
&#xD;
      The European Consortium of Lipodystrophy (ECLip) consists of an association of European&#xD;
      experts in the field of lipodystrophy. It has set up a Registry Board to implement a registry&#xD;
      for patients with lipodystrophy using the Open Source Software OSSE (Open Source Registry&#xD;
      System for Rare Diseases in the EU), which is a web based platform focused on a federated&#xD;
      approach that allows to perform distributed searches which are designed to comply data&#xD;
      protection requirements and preserve data sovereignty. To ensure data protection, medical and&#xD;
      identifying data will be stored on two different servers both run by the Institute for&#xD;
      Epidemiology and Medical Biometry of the University of Ulm.&#xD;
&#xD;
      Medical centers from all over the world where patients are treated with lipodystrophy are&#xD;
      invited to join the ECLip Registry and to become ECLip Registry members. Upon registration,&#xD;
      they can enter patient data after they have obtained local ethic committee permission and the&#xD;
      patient in question has given written consent to this. Data entry is done at the individual&#xD;
      locations via a web-based user interface. Identifying data are recorded directly into the&#xD;
      identity management system. Communication between the identity management and the OSSE&#xD;
      registry happens via a web browser.&#xD;
&#xD;
      The aim of the patient registry is to compile data on the natural history of each different&#xD;
      sub-group of lipodystrophies, their comorbidities, treatment options used and medical and&#xD;
      quality of life out-come for the patients. For this, the following data retrieved from&#xD;
      regular patient visits are collected:&#xD;
&#xD;
        -  Precise diagnosis including moleculargenetic results&#xD;
&#xD;
        -  Clinical presentation and comorbidities&#xD;
&#xD;
        -  Laboratory changes and results of diagnostic procedures&#xD;
&#xD;
        -  Natural course of the disease including age at onset of disease and comorbidities&#xD;
&#xD;
        -  Family history&#xD;
&#xD;
      Research within this registry can be performed by participating clinicians/researchers and&#xD;
      third parties after a research proposal has be accepted by the responsible committee of the&#xD;
      ECLip. The registry aims to answer the following questions&#xD;
&#xD;
        -  new insights into the pathophysiology of lipodystrophy&#xD;
&#xD;
        -  improve therapeutic options for the patients&#xD;
&#xD;
        -  compile information material for patients, families and relevant professionals&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 16, 2017</start_date>
  <completion_date type="Anticipated">January 2068</completion_date>
  <primary_completion_date type="Anticipated">January 2068</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>50 Years</target_duration>
  <primary_outcome>
    <measure>Age at death</measure>
    <time_frame>after 20 years</time_frame>
    <description>patients are followed regularly, age at death (years) will be documented</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in somatic comorbidities under standard treatment</measure>
    <time_frame>yearly for 50 years</time_frame>
    <description>standardized physical examination, laboratory and instrument based tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>genotype-phenotype correlation for patients with familial lipodystrophy</measure>
    <time_frame>every 5 years for 50 years</time_frame>
    <description>molecular genetic results will be compared to results from standardized physical examination, laboratory and instrument based tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>age at onset of metabolic complications</measure>
    <time_frame>yearly for 50 years</time_frame>
    <description>metabolic complications will be assessed via standardized physical examination, laboratory and instrument based tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>age at onset orthopedic complications</measure>
    <time_frame>yearly for 50 years</time_frame>
    <description>orthopedic complications will be assessed via standardized physical examination, laboratory and instrument based tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>age at onset neuromuscular complications</measure>
    <time_frame>yearly for 50 years</time_frame>
    <description>neuromuscular compliations will be assessed via standardized physical examination, laboratory and instrument based tests</description>
  </secondary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Lipodystrophy Acquired</condition>
  <condition>Lipodystrophy Congenital</condition>
  <eligibility>
    <study_pop>
      <textblock>
        all patients with lipodystrophy not due to anti-retroviral drugs presenting to a&#xD;
        participating center might be entered&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  lipodystrophy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  lipodystrophy due to anti-retroviral drugs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Wabitsch, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>University of Ulm</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Araujo-Vilar, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Santiago de Compostela University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julia von Schnurbein, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Ulm</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gabriele Nagel, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Ulm</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Camille Vatier, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pierre et Marie Curie School of Medicine (Paris)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie-Christine Vantyghem, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lille University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giovanni Ceccarini, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Endocrine Unit, University Hospital of Pisa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ekaterina Sorkina, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Endocrinology Research Centre, Moscow</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Savage, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cambridge Metabolic Research Laboratories</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julia von Schnurbein, Dr.</last_name>
    <phone>0049 731 500</phone>
    <phone_ext>57401</phone_ext>
    <email>julia.schnurbein@uniklinik-ulm.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martin Wabitsch, Prof. Dr.</last_name>
    <phone>0049 731 500</phone>
    <phone_ext>57401</phone_ext>
    <email>martin.wabitsch@uniklinik-ulm.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Scherer, M.D.</last_name>
      <email>thomas.scherer@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Marianna Beghini, M.D.</last_name>
      <email>marianna.beghini@meduniwien.ac.at</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cyprus Institute of Neurology &amp; Genetics</name>
      <address>
        <city>Nicosia</city>
        <country>Cyprus</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Georges Tanteles, Dr.</last_name>
      <email>gtanteles@cing.ac.cy</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lille University</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie-Christine Vantyghem, Prof.</last_name>
      <email>marie-christine.vantyghem@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Géraldine Lavergne</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Sophie Paranthoen</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's hospital la Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas Levy, Prof.</last_name>
      <email>nicolas.levy@univ-amu.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pierre et Marie Curie School of Medicine, Sorbonne University</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camille Vatier, Dr.</last_name>
      <email>camille.vatier@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Corinne Vigouroux, Prof. Dr.</last_name>
      <email>corinne.vigouroux@inserm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Isabelle Jeru, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Human Genetics, Martin Luther University Halle-Wittenberg</name>
      <address>
        <city>Halle</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katrin Hoffmann</last_name>
      <email>katrin.hoffmann@uk-halle.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine (Endocrinology and Nephrology), University of Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Konstanze Miehle, Dr.</last_name>
      <email>Konstanze.Miehle@medizin.uni-leipzig.de</email>
    </contact>
    <investigator>
      <last_name>Michael Stumvoll, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mathias Faßhauer, Prof. Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Med. Klinik B für Gastroenterologie und Hepatologie, Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hartmut Schmidt, Prof.</last_name>
      <email>hepar@ukmuenster.de</email>
    </contact>
    <contact_backup>
      <last_name>Elena Vorona, Dr. med.</last_name>
      <email>Elena.Vorona@ukmuenster.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Dept for Pediatrics and Adolescent Medicine, University of Ulm: Interdisciplinary obesity clinic</name>
      <address>
        <city>Ulm</city>
        <zip>89075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Wabitsch, Prof. Dr.</last_name>
      <phone>0049 731 500</phone>
      <phone_ext>57401</phone_ext>
      <email>martin.wabitsch@uniklinik-ulm.de</email>
    </contact>
    <contact_backup>
      <last_name>Julia von Schnurbein, Dr. med.</last_name>
      <phone>0049 731 500</phone>
      <phone_ext>57401</phone_ext>
      <email>julia.schnurbein@uniklinik-ulm.de</email>
    </contact_backup>
    <investigator>
      <last_name>Martin Wabitsch, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julia von Schnurbein, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Szeged, Department of Internal Medicine</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Csajbok, Dr.</last_name>
      <email>recepcio@gendiagnosztika.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Endocrinology Unit, Department of Clinical and Medical science, S. Orsola-Malpighi Hospital , University of Bologna</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandra Gambineri, Ass. Prof.</last_name>
      <email>alessandra.gambineri@aosp.bo.it</email>
    </contact>
    <contact_backup>
      <last_name>Giovanna Lattanzi</last_name>
      <email>lattanzi@area.bo.cnr.it</email>
    </contact_backup>
    <investigator>
      <last_name>Carolina Cecchetti</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universita del piemonte Orientale</name>
      <address>
        <city>Novara</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Flavia Prodam, Dr</last_name>
      <email>flavia.prodam@med.uniupo.it</email>
    </contact>
    <contact_backup>
      <last_name>Gianluca Aimaretti, Prof</last_name>
      <email>gianluca.aimaretti@med.uniupo.it</email>
    </contact_backup>
    <investigator>
      <last_name>Tommaso Daffara, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endocrine Unit of University Hospital of Pisa</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Ceccarini, Prof. Dr.</last_name>
      <email>giovanni.ceccarini@unipi.it</email>
    </contact>
    <contact_backup>
      <last_name>Ferruccio Santini, Prof. Dr.</last_name>
      <phone>+39 050 544</phone>
      <phone_ext>723</phone_ext>
      <email>ferruccio.santini@med.unipi.it</email>
    </contact_backup>
    <investigator>
      <last_name>Federica Ferrari, Dott.ssa</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tor Vergata University - Policlinico of Tor Vergata</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giusepe Novelli, Prof</last_name>
      <email>novelli@med.uniroma2.it</email>
    </contact>
    <contact_backup>
      <last_name>Maria Rosaria D'Apice, Dr</last_name>
      <email>d.apice@med.uniroma2.it</email>
    </contact_backup>
    <investigator>
      <last_name>Paolo Sbraccia, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center, University of Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jagiellonian University</name>
      <address>
        <city>Kraków</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maciej T. Malecki, Prof. Dr.</last_name>
      <email>malecki_malecki@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Magdalena Szopa, Dr.</last_name>
      <email>magda.szopa@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Abel Salazar Biomedical Sciences Institute - University of Porto</name>
      <address>
        <city>Porto</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ermelinda Santos Silva, Prof. Dra</last_name>
      <email>u20868@chporto.min-saude.pt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar de São João</name>
      <address>
        <city>Porto</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paula Freitas</last_name>
      <email>paula_freitas@sapo.pt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Endocrinology Research Centre</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ekaterina Sorkina, MD</last_name>
      <email>sorkina@bk.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Ljubljana - Clinical Institute of Medical Genetics</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karin Writzl, Dr.</last_name>
      <phone>003861522</phone>
      <phone_ext>6031</phone_ext>
      <email>karinwritzl@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Iztok Stotl, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Santiago de Compostela University</name>
      <address>
        <city>Santiago de Compostela</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Araujo-Vilar, Prof. Dr.</last_name>
      <email>david.araujo@usc.es</email>
    </contact>
    <contact_backup>
      <last_name>Antía Fernández Pombo</last_name>
      <email>antia.fernandez.pombo@rai.usc.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Dokuz Eylul University School of Medicine</name>
      <address>
        <city>İzmir</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Baris Akinci</last_name>
      <email>barisakincimd@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Cambridge Metabolic Research Laboratories</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Savage, Prof.</last_name>
      <email>dbs23@medschl.cam.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Claire Adams</last_name>
      <email>ca337@medschl.cam.ac.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Cyprus</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Russian Federation</country>
    <country>Slovenia</country>
    <country>Spain</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>von Schnurbein J, Adams C, Akinci B, Ceccarini G, D'Apice MR, Gambineri A, Hennekam RCM, Jeru I, Lattanzi G, Miehle K, Nagel G, Novelli G, Santini F, Santos Silva E, Savage DB, Sbraccia P, Schaaf J, Sorkina E, Tanteles G, Vantyghem MC, Vatier C, Vigouroux C, Vorona E, Araújo-Vilar D, Wabitsch M. European lipodystrophy registry: background and structure. Orphanet J Rare Dis. 2020 Jan 15;15(1):17. doi: 10.1186/s13023-020-1295-y.</citation>
    <PMID>31941540</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 14, 2018</study_first_submitted>
  <study_first_submitted_qc>June 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2018</study_first_posted>
  <last_update_submitted>August 10, 2021</last_update_submitted>
  <last_update_submitted_qc>August 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ulm</investigator_affiliation>
    <investigator_full_name>Julia von Schnurbein</investigator_full_name>
    <investigator_title>Prinicipal Investigator</investigator_title>
  </responsible_party>
  <keyword>lipodystrophy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipodystrophy, Congenital Generalized</mesh_term>
    <mesh_term>Lipodystrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Researches participating in the ECLip registry and third parties independently can request to perform research with the data.</ipd_description>
    <ipd_time_frame>As soon as data is entered into the registry, request for data analysis can be handed in.</ipd_time_frame>
    <ipd_access_criteria>Researchers participating in the ECLip registry and independent third parties can request to perform research with the data. For this a formal request for data analysis (data evaluation form; available from the Registry Board) has to be handed to the leader of the Registry Board who will pass it to all board members. These will form a proposal for the Registry members.</ipd_access_criteria>
    <ipd_url>https://www.eclip-web.org/information/registry/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

